Redcare Pharmacy valuation

RDC · Xetra · EUR

Compare Redcare Pharmacy
€63.40Change from previous close: −1.93%Absolute change: −€1.25

Close · November 20, 2026

Valuation

The average price target of 10 analysts is €91.60.

Data as of November 21, 2026

Redcare Pharmacy compared with similar companies

Redcare Pharmacy's Forward P/E: 49.4, +208% against the median of a group of 9 similar companies (16.0).

Redcare Pharmacy's metrics compared with similar companies
MetricRedcare PharmacyMedian25th–75th percentileBand
Forward P/E49.416.012.5 – 19.5High
EV/EBITDA52.811.110.1 – 18.5High
Price/book2.913.102.46 – 7.19Middle
Price/sales0.400.660.48 – 1.28Low
Gross margin21.5%25.4%24.3% – 40.4%Low
Operating margin0.3%6.1%4.3% – 6.5%Low
Net margin-1.0%3.1%2.1% – 6.8%Low
ROE-7.1%19.2%10.9% – 34.5%Low
Debt/equity0.741.150.64 – 2.44Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same and related industries, similar size

Other metrics

Valuation multiples

Market cap
€1.34B
Enterprise value
€1.61B
P/E (trailing 12 months)
-34.7
EV/revenue
0.48

Profitability and growth

ROA
0.5%
ROIC
0.7%
Revenue growth (year over year)
17.7%
Earnings growth (year over year)
-50.4%

Financial health

Total cash
€132.4M
Total debt
€354.5M
Current ratio
1.62
Quick ratio
0.81
Piotroski F-Score
3.00

Dividends

Dividend yield
0.0%

Analysts and estimates

Average price target
€91.60
Median price target
€90.50
High price target
€125.00
Low price target
€72.00
Analysts with a price target
10
Consensus
Buy
Forward EPS
€1.35
EPS estimate, current year
-€0.31

Shares and trading

Beta
1.45
Average volume
84.09K
Shares outstanding
20.11M
Float
19.2M
Institutional ownership
36.2%
Insider ownership
18.7%